• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

心力衰竭住院患者出院时血钾水平与长期死亡率的关联

Association of Potassium Level at Discharge with Long-Term Mortality in Hospitalized Patients with Heart Failure.

作者信息

Miura Yusuke, Higuchi Satoshi, Kohno Takashi, Shiraishi Yasuyuki, Kitamura Mitsunobu, Nagatomo Yuji, Takei Makoto, Nakano Shintaro, Goda Ayumi, Soejima Kyoko, Kohsaka Shun, Yoshikawa Tsutomu

机构信息

Department of Cardiovascular Medicine, Kyorin University Hospital, Tokyo 181-8611, Japan.

Division of Cardiology, Department of Medicine, Showa University School of Medicine, Tokyo 142-8555, Japan.

出版信息

J Clin Med. 2022 Dec 11;11(24):7358. doi: 10.3390/jcm11247358.

DOI:10.3390/jcm11247358
PMID:36555973
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9782550/
Abstract

Dyskalemia (hypokalemia and hyperkalemia) is a common comorbidity of heart failure (HF). Although dyskalemia is associated with poor prognosis, different prognostic impacts of hypo- and hyperkalemia remain vastly unclear. This study investigated the association of dyskalemia with prognosis in HF patients, especially the mode of death and left ventricular ejection fraction (LVEF). The multicenter study included 3398 patients hospitalized for HF. Patients were divided into three groups based on serum potassium levels at discharge: hypokalemia (<3.5 mEq/L; n = 115 (3.4%)), normokalemia (3.5−5.0 mEq/L; n = 2960 (87.1%)), and hyperkalemia (≥5.0 mEq/L; n = 323 (9.5%)). Two-year all-cause, cardiac, and non-cardiac mortality was evaluated. Association of serum potassium with two-year mortality demonstrated a U-shaped curve, with a worse prognosis for patients with hypokalemia. All-cause mortality at two-years did not differ among the three groups. Hypokalemia was associated with 2-year cardiac death (adjusted hazard ratio (HR), 2.60; 95% confidence interval (CI), 1.20−5.64) in HF with reduced ejection fraction (HFrEF; LVEF < 40%), but not in non-HFrEF. Regardless of LVEF, hyperkalemia was not independently associated with any mortality. Hypokalemia was independently associated with cardiac death, particularly in HFrEF patients. Such an association was not observed in hyperkalemia regardless of LVEF.

摘要

钾代谢异常(低钾血症和高钾血症)是心力衰竭(HF)常见的合并症。尽管钾代谢异常与预后不良相关,但低钾血症和高钾血症对预后的不同影响仍极不清楚。本研究调查了钾代谢异常与HF患者预后的关系,尤其是死亡方式和左心室射血分数(LVEF)。这项多中心研究纳入了3398例因HF住院的患者。根据出院时的血清钾水平将患者分为三组:低钾血症(<3.5 mEq/L;n = 115(3.4%))、血钾正常(3.5−5.0 mEq/L;n = 2960(87.1%))和高钾血症(≥5.0 mEq/L;n = 323(9.5%))。评估了两年的全因死亡率、心脏死亡率和非心脏死亡率。血清钾与两年死亡率的关联呈U形曲线,低钾血症患者的预后较差。三组患者两年的全因死亡率无差异。低钾血症与射血分数降低的HF(HFrEF;LVEF < 40%)患者的两年心脏死亡相关(校正风险比(HR),2.60;95%置信区间(CI),1.20−5.64),但在非HFrEF患者中无此关联。无论LVEF如何,高钾血症均与任何死亡率无独立关联。低钾血症与心脏死亡独立相关,尤其是在HFrEF患者中。无论LVEF如何,高钾血症均未观察到这种关联。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4284/9782550/e58bae36cd1a/jcm-11-07358-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4284/9782550/e1daaa1e8dc1/jcm-11-07358-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4284/9782550/322d704e5222/jcm-11-07358-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4284/9782550/e58bae36cd1a/jcm-11-07358-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4284/9782550/e1daaa1e8dc1/jcm-11-07358-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4284/9782550/322d704e5222/jcm-11-07358-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4284/9782550/e58bae36cd1a/jcm-11-07358-g003.jpg

相似文献

1
Association of Potassium Level at Discharge with Long-Term Mortality in Hospitalized Patients with Heart Failure.心力衰竭住院患者出院时血钾水平与长期死亡率的关联
J Clin Med. 2022 Dec 11;11(24):7358. doi: 10.3390/jcm11247358.
2
Influence of dyskalemia at admission and early dyskalemia correction on survival and cardiac events of critically ill patients.入院时电解质紊乱及早期纠正电解质紊乱对危重症患者生存及心脏事件的影响。
Crit Care. 2019 Dec 19;23(1):415. doi: 10.1186/s13054-019-2679-z.
3
Dyskalemia, its patterns, and prognosis among patients with incident heart failure: A nationwide study of US veterans.伴发的电解质异常及其模式和预后在新发心力衰竭患者中的表现:一项针对美国退伍军人的全国性研究。
PLoS One. 2019 Aug 8;14(8):e0219899. doi: 10.1371/journal.pone.0219899. eCollection 2019.
4
Serum potassium dynamics during acute heart failure hospitalization.急性心力衰竭住院期间的血清钾动态变化。
Clin Res Cardiol. 2022 Apr;111(4):368-379. doi: 10.1007/s00392-020-01753-3. Epub 2020 Oct 17.
5
Incidence, Predictors, and Outcome Associations of Dyskalemia in Heart Failure With Preserved, Mid-Range, and Reduced Ejection Fraction.射血分数保留、中间范围和降低的心衰患者中电解质紊乱的发生率、预测因素和预后相关性。
JACC Heart Fail. 2019 Jan;7(1):65-76. doi: 10.1016/j.jchf.2018.10.003. Epub 2018 Dec 12.
6
[Association between serum potassium levels and all-cause mortality in patients with acute heart failure].[急性心力衰竭患者血清钾水平与全因死亡率之间的关联]
Zhonghua Yi Xue Za Zhi. 2023 Mar 14;103(10):727-732. doi: 10.3760/cma.j.cn112137-20220707-01504.
7
Clinical outcomes by serum potassium levels for patients hospitalized for heart failure: Secondary analysis of data from the China National Heart Failure Registry.因心力衰竭住院患者的血清钾水平的临床结局:中国心力衰竭注册登记研究数据的二次分析。
Clin Cardiol. 2023 Nov;46(11):1345-1352. doi: 10.1002/clc.24114. Epub 2023 Aug 14.
8
Long-Term Potassium Monitoring and Dynamics in Heart Failure and Risk of Mortality.心力衰竭中长期钾监测与动力学和死亡率的关系。
Circulation. 2018 Mar 27;137(13):1320-1330. doi: 10.1161/CIRCULATIONAHA.117.030576. Epub 2017 Oct 12.
9
High- Versus Low-dose Losartan and Serum Potassium: An Analysis From HEAAL.高剂量与低剂量氯沙坦及血清钾:来自HEAAL的分析
J Card Fail. 2023 Jan;29(1):45-52. doi: 10.1016/j.cardfail.2022.09.008. Epub 2022 Oct 14.
10
Clinical characteristics of hospitalized heart failure patients with preserved, mid-range, and reduced ejection fractions in Japan.日本住院心力衰竭患者射血分数保留、中间范围和降低的临床特征。
ESC Heart Fail. 2019 Jun;6(3):475-486. doi: 10.1002/ehf2.12418. Epub 2019 Mar 3.

引用本文的文献

1
Cachectic biomarkers as confounders behind the obesity paradox in patients with acute decompensated heart failure.恶病质生物标志物作为急性失代偿性心力衰竭患者肥胖悖论背后的混杂因素。
Int J Obes (Lond). 2025 May;49(5):888-895. doi: 10.1038/s41366-025-01716-6. Epub 2025 Jan 26.
2
Impact of multiple comorbidities on long-term mortality in older patients following transcatheter aortic valve replacement.多种合并症对老年患者经导管主动脉瓣置换术后长期死亡率的影响。
Heliyon. 2024 Aug 23;10(17):e36724. doi: 10.1016/j.heliyon.2024.e36724. eCollection 2024 Sep 15.
3
Potassium levels and the risk of all-cause and cardiovascular mortality among patients with cardiovascular diseases: a meta-analysis of cohort studies.

本文引用的文献

1
Reduction of heart failure guideline-directed medication during hospitalization: prevalence, risk factors, and outcomes.住院期间心力衰竭指南指导药物的减少:流行率、危险因素和结局。
ESC Heart Fail. 2022 Oct;9(5):3298-3307. doi: 10.1002/ehf2.14051. Epub 2022 Jul 7.
2
Guideline-directed medical therapy in patients undergoing transcatheter edge-to-edge repair for secondary mitral regurgitation.经导管缘对缘修复治疗继发性二尖瓣反流患者的指南指导下的药物治疗
Eur J Heart Fail. 2022 Nov;24(11):2152-2161. doi: 10.1002/ejhf.2613. Epub 2022 Jul 27.
3
Prevention of sudden death in heart failure with reduced ejection fraction: do we still need an implantable cardioverter-defibrillator for primary prevention?
钾水平与心血管疾病患者全因和心血管死亡率的关系:队列研究的荟萃分析。
Nutr J. 2024 Jan 10;23(1):8. doi: 10.1186/s12937-023-00888-z.
心力衰竭伴射血分数降低患者的猝死预防:我们是否仍需要植入式心脏复律除颤器进行一级预防?
Eur J Heart Fail. 2022 Sep;24(9):1460-1466. doi: 10.1002/ejhf.2594. Epub 2022 Jul 16.
4
Prognostic significance of serum potassium in patients hospitalized for acute heart failure.血清钾在急性心力衰竭住院患者中的预后意义。
ESC Heart Fail. 2022 Aug;9(4):2357-2366. doi: 10.1002/ehf2.13925. Epub 2022 May 11.
5
2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.2022年美国心脏协会/美国心脏病学会/美国心力衰竭学会心力衰竭管理指南:美国心脏病学会/美国心脏协会临床实践指南联合委员会报告
Circulation. 2022 May 3;145(18):e895-e1032. doi: 10.1161/CIR.0000000000001063. Epub 2022 Apr 1.
6
Representativeness of the GALACTIC-HF Clinical Trial in Patients Having Heart Failure With Reduced Ejection Fraction.GALACTIC-HF 临床试验在心衰射血分数降低患者中的代表性。
J Am Heart Assoc. 2022 Apr 5;11(7):e023766. doi: 10.1161/JAHA.121.023766. Epub 2022 Mar 24.
7
Different Impact of Beta-Blockers on Long-Term Mortality in Heart Failure Patients with and without Chronic Obstructive Pulmonary Disease.β受体阻滞剂对合并和不合并慢性阻塞性肺疾病的心力衰竭患者长期死亡率的不同影响。
J Clin Med. 2021 Sep 25;10(19):4378. doi: 10.3390/jcm10194378.
8
2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure.2021年欧洲心脏病学会急性和慢性心力衰竭诊断与治疗指南。
Eur Heart J. 2021 Sep 21;42(36):3599-3726. doi: 10.1093/eurheartj/ehab368.
9
Abnormalities of Potassium in Heart Failure: JACC State-of-the-Art Review.心力衰竭中的钾异常:JACC 最新综述。
J Am Coll Cardiol. 2020 Jun 9;75(22):2836-2850. doi: 10.1016/j.jacc.2020.04.021.
10
Unravelling the interplay between hyperkalaemia, renin-angiotensin-aldosterone inhibitor use and clinical outcomes. Data from 9222 chronic heart failure patients of the ESC-HFA-EORP Heart Failure Long-Term Registry.揭示高钾血症、肾素-血管紧张素-醛固酮抑制剂使用与临床结局之间的相互作用。来自 ESC-HFA-EORP 心力衰竭长期注册研究的 9222 例慢性心力衰竭患者的数据。
Eur J Heart Fail. 2020 Aug;22(8):1378-1389. doi: 10.1002/ejhf.1793. Epub 2020 Apr 3.